These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36185705)

  • 1. Sodium
    Shah CV; Robbins TS; Sparks MA
    Kidney Med; 2022 Oct; 4(10):100533. PubMed ID: 36185705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SGLT2 Inhibitors for Treatment of Refractory Hypomagnesemia: A Case Report of 3 Patients.
    Ray EC; Boyd-Shiwarski CR; Liu P; Novacic D; Cassiman D
    Kidney Med; 2020; 2(3):359-364. PubMed ID: 32734255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Home Subcutaneous Magnesium Infusion in Refractory Hypomagnesemia: A Case Report.
    Tokarski RM; Knecht V; Bezjak JD; Ray EC
    Kidney Med; 2023 Apr; 5(4):100611. PubMed ID: 36941847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tubular effects of sodium-glucose cotransporter 2 inhibitors: intended and unintended consequences.
    Dominguez Rieg JA; Xue J; Rieg T
    Curr Opin Nephrol Hypertens; 2020 Sep; 29(5):523-530. PubMed ID: 32701600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypomagnesemia: an evidence-based approach to clinical cases.
    Assadi F
    Iran J Kidney Dis; 2010 Jan; 4(1):13-9. PubMed ID: 20081299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum magnesium associated with SGLT2 inhibitor use in type 2 diabetes patients: a meta-analysis of randomised controlled trials.
    Tang H; Zhang X; Zhang J; Li Y; Del Gobbo LC; Zhai S; Song Y
    Diabetologia; 2016 Dec; 59(12):2546-2551. PubMed ID: 27628105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Dapagliflozin and Magnesium Supplementation on Renal Magnesium Handling and Magnesium Homeostasis in Metabolic Syndrome.
    Ng HY; Kuo WH; Tain YL; Leung FF; Lee WC; Lee CT
    Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The current role of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes mellitus management.
    Xu B; Li S; Kang B; Zhou J
    Cardiovasc Diabetol; 2022 May; 21(1):83. PubMed ID: 35614469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of the blood pressure-lowering effect of sodium-glucose cotransporter 2 inhibitors in obese patients with type 2 diabetes.
    Kawasoe S; Maruguchi Y; Kajiya S; Uenomachi H; Miyata M; Kawasoe M; Kubozono T; Ohishi M
    BMC Pharmacol Toxicol; 2017 Apr; 18(1):23. PubMed ID: 28391776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypomagnesemia and renal magnesium wasting in renal transplant recipients receiving cyclosporine.
    Barton CH; Vaziri ND; Martin DC; Choi S; Alikhani S
    Am J Med; 1987 Oct; 83(4):693-9. PubMed ID: 3314493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal and Cardiovascular Effects of sodium-glucose cotransporter 2 (SGLT2) inhibition in combination with loop Diuretics in diabetic patients with Chronic Heart Failure (RECEDE-CHF): protocol for a randomised controlled double-blind cross-over trial.
    Mordi NA; Mordi IR; Singh JS; Baig F; Choy AM; McCrimmon RJ; Struthers AD; Lang CC
    BMJ Open; 2017 Oct; 7(10):e018097. PubMed ID: 29042392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of sodium-glucose cotransporter 2 inhibitors on blood pressure.
    Reed JW
    Vasc Health Risk Manag; 2016; 12():393-405. PubMed ID: 27822054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal and Cardiovascular Effects of SGLT2 Inhibition in Combination With Loop Diuretics in Patients With Type 2 Diabetes and Chronic Heart Failure: The RECEDE-CHF Trial.
    Mordi NA; Mordi IR; Singh JS; McCrimmon RJ; Struthers AD; Lang CC
    Circulation; 2020 Nov; 142(18):1713-1724. PubMed ID: 32865004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Empagliflozin in Heart Failure: Diuretic and Cardiorenal Effects.
    Griffin M; Rao VS; Ivey-Miranda J; Fleming J; Mahoney D; Maulion C; Suda N; Siwakoti K; Ahmad T; Jacoby D; Riello R; Bellumkonda L; Cox Z; Collins S; Jeon S; Turner JM; Wilson FP; Butler J; Inzucchi SE; Testani JM
    Circulation; 2020 Sep; 142(11):1028-1039. PubMed ID: 32410463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose Lowering Efficacy and Pleiotropic Effects of Sodium-Glucose Cotransporter 2 Inhibitors.
    Kuchay MS; Farooqui KJ; Mishra SK; Mithal A
    Adv Exp Med Biol; 2021; 1307():213-230. PubMed ID: 32006266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of sodium-glucose cotransporter 2 inhibitors on left ventricular function: current evidence and future directions.
    Lan NSR; Fegan PG; Yeap BB; Dwivedi G
    ESC Heart Fail; 2019 Oct; 6(5):927-935. PubMed ID: 31400090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteinuria-associated renal magnesium wasting leads to hypomagnesemia: a common electrolyte abnormality in chronic kidney disease.
    Oka T; Hamano T; Sakaguchi Y; Yamaguchi S; Kubota K; Senda M; Yonemoto S; Shimada K; Matsumoto A; Hashimoto N; Mori D; Monden C; Takahashi A; Obi Y; Yamamoto R; Takabatake Y; Kaimori JY; Moriyama T; Horio M; Matsui I; Isaka Y
    Nephrol Dial Transplant; 2019 Jul; 34(7):1154-1162. PubMed ID: 29796601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium-Glucose Cotransporter 2 (SGLT2) Inhibition in Kidney Transplant Recipients with Diabetes Mellitus.
    Mahling M; Schork A; Nadalin S; Fritsche A; Heyne N; Guthoff M
    Kidney Blood Press Res; 2019; 44(5):984-992. PubMed ID: 31437852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus: Cardiovascular and Kidney Effects, Potential Mechanisms, and Clinical Applications.
    Heerspink HJ; Perkins BA; Fitchett DH; Husain M; Cherney DZ
    Circulation; 2016 Sep; 134(10):752-72. PubMed ID: 27470878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus-associated hypomagnesemia in renal transplant recipients.
    Navaneethan SD; Sankarasubbaiyan S; Gross MD; Jeevanantham V; Monk RD
    Transplant Proc; 2006 Jun; 38(5):1320-2. PubMed ID: 16797291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.